LM

Layton Mills

Mr. Mills is an experienced life-sciences executive, having worked in the biotechnology and life sciences industries for over 15 years, developing experience across human and animal health in pharmaceutical and consumer healthcare. Mr Mills is also the founder and Managing Director of Subgenix Lifesciences, an early-stage biotechnology Company using conventional drug development strategies to unlock the broader therapeutic potential of psychedelic compounds for rare and underserved health needs. He has international business experience having been involved in corporate business activities across Europe, Asia and North America, including government-led trade incentives with the Canberra Business Chamber.

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/24N/AN/A120,000N/A
01/06/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
28/03/24
Issued
120,000$0.410$49,200Issue of options